Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
23
OSCR Quote, Financials, Valuation and Earnings
Last price:
$13.37
Seasonality move
:
44.5%
Day range:
$13.05 - $13.66
52-week range:
$8.44 - $23.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.44x
P/B ratio:
2.85x
Volume:
1.4M
Avg. volume:
4.6M
1-year change:
45.97%
Market cap:
$3.3B
Revenue:
$5.9B
EPS (TTM):
-$0.06
Analysts' Opinion
-
Consensus RatingOscar Health has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $19.00, Oscar Health has an estimated upside of 44.46% from its current price of $13.40.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $16.00 representing 100% downside risk from its current price of $13.40.
Fair Value
-
According to the consensus of 4 analysts, Oscar Health has 44.46% upside to fair value with a price target of $19.00 per share.
OSCR vs. S&P 500
-
Over the past 5 trading days, Oscar Health has underperformed the S&P 500 by -3.58% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Oscar Health does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Oscar Health has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Oscar Health reported revenues of $2.4B.
Earnings Growth
-
Oscar Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Oscar Health reported earnings per share of -$0.22.
Enterprise value:
1.9B
EV / Invested capital:
1.30x
Price / LTM sales:
0.44x
EV / EBIT:
31.55x
EV / Revenue:
0.23x
PEG ratio (5yr expected):
--
EV / Free cash flow:
2.11x
Price / Operating cash flow:
3.97x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.69%
Net Income Margin (TTM):
0.35%
Return On Equity:
2.86%
Return On Invested Capital:
2.21%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $3.6B | $5.5B | $8.2B | $1.4B | $2.4B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$2.75 | -$1.59 | -$0.06 | -$0.29 | -$0.22 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $1.8B | $3.9B | $3B | $2.3B | |
| Total Assets | -- | $3.2B | $4.3B | $3.3B | $4.5B | |
| Current Liabilities | -- | $1.3B | $2.5B | $1.7B | $2.5B | |
| Total Liabilities | -- | $1.6B | $3.2B | $2.4B | $3.3B | |
| Total Equity | -- | $1.6B | $1.1B | $921.4M | $1.2B | |
| Total Debt | -- | -- | $297.8M | $298.6M | $299.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $263.4M | -$417.6M | $928.2M | -$1.1B | -$500.1M | |
| Cash From Investing | $460.3M | -$302M | -$1.2B | $225.3M | -$577.8M | |
| Cash From Financing | $313.6M | $5.9M | $65.6M | $2.3M | $18.6M | |
| Free Cash Flow | $234.3M | -$444.2M | $901.1M | -$1.2B | -$507.7M | |
OSCR
Sector
Market Cap
$3.3B
$700.3M
Price % of 52-Week High
56.33%
88.31%
Dividend Yield
0%
2.2%
Shareholder Yield
--
3.87%
1-Year Price Total Return
45.97%
7.75%
Beta (5-Year)
--
0.737
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$13.63
200-day SMA
Sell
Level
$17.33
Bollinger Bands (100)
Sell
Level
14.98 - 19.78
Chaikin Money Flow
Sell
Level
-108.1M
20-day SMA
Sell
Level
$15.22
Relative Strength Index (RSI14)
Sell
Level
39.27
ADX Line
Buy
Level
18.06
Williams %R
Buy
Level
-92.1875
50-day SMA
Sell
Level
$15.76
MACD (12, 26)
Sell
Level
-0.81
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Sell
Level
-24.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.0609)
Sell
CA Score
(Annual)
Level (-1.506)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (2.4417)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
Stock Forecast FAQ
In the current month, OSCR has received 2 Buy ratings 1 Hold ratings, and 1 Sell ratings. The OSCR average analyst price target in the past 3 months is $19.00.
-
Where Will Oscar Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Oscar Health share price will rise to $19.00 per share over the next 12 months.
-
What Do Analysts Say About Oscar Health?
Analysts are divided on their view about Oscar Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Oscar Health is a Sell and believe this share price will drop from its current level to $16.00.
-
What Is Oscar Health's Price Target?
The price target for Oscar Health over the next 1-year time period is forecast to be $19.00 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is OSCR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Oscar Health is a Buy. 2 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OSCR?
You can purchase shares of Oscar Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oscar Health shares.
-
What Is The Oscar Health Share Price Today?
Oscar Health was last trading at $13.37 per share. This represents the most recent stock quote for Oscar Health. Yesterday, Oscar Health closed at $13.40 per share.
-
How To Buy Oscar Health Stock Online?
In order to purchase Oscar Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
